(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 28553.90 | 25159.60 | 13.49 | 117716.70 | 110559.30 | 6.47 | 117716.70 | 110559.30 | 6.47 |
| Other Income | 570.30 | 660.70 | -13.68 | 2169.90 | 1290.90 | 68.09 | 2169.90 | 1290.90 | 68.09 |
| PBIDT | 5171.50 | 4911.20 | 5.30 | 4261.30 | 21731.50 | -80.39 | 4261.30 | 21731.50 | -80.39 |
| Interest | 245.80 | 123.10 | 99.68 | 734.70 | 406.20 | 80.87 | 734.70 | 406.20 | 80.87 |
| PBDT | 4925.70 | 4788.10 | 2.87 | 3526.60 | 21325.30 | -83.46 | 3526.60 | 21325.30 | -83.46 |
| Depreciation | 1310.20 | 1250.10 | 4.81 | 5141.90 | 5028.30 | 2.26 | 5141.90 | 5028.30 | 2.26 |
| PBT | 3615.50 | 3538.00 | 2.19 | -1615.30 | 16297.00 | -109.91 | -1615.30 | 16297.00 | -109.91 |
| TAX | 3974.40 | 374.40 | 961.54 | 271.70 | 3710.80 | -92.68 | 271.70 | 3710.80 | -92.68 |
| Deferred Tax | 3419.40 | 236.70 | 1344.61 | -306.30 | 82.30 | -472.17 | -306.30 | 82.30 | -472.17 |
| PAT | -358.90 | 3163.60 | -111.34 | -1887.00 | 12586.20 | -114.99 | -1887.00 | 12586.20 | -114.99 |
| Equity | 909.00 | 907.40 | 0.18 | 909.00 | 907.40 | 0.18 | 909.00 | 907.40 | 0.18 |
| PBIDTM(%) | 18.11 | 19.52 | -7.22 | 3.62 | 19.66 | -81.58 | 3.62 | 19.66 | -81.58 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: